Anthony Radford
Director/Board Member chez GENETIC SIGNATURES LIMITED
Fortune : 109 004 $ au 31/03/2024
Profil
Anthony J.
Radford is the founder of Cellestis Pty Ltd.
which was founded in 2000, where he held the titles of CEO, Director & Managing Director from 2011 to 2012.
He is currently a Non-Executive Director at Genetic Signatures Ltd.
since 2015.
Dr. Radford's former positions include being a Senior Member at Commonwealth Scientific & Industrial Research Organisation from 1985 to 1992, and Head-Development at Amrad Operations Pty Ltd.
from 1993 to 2000.
Dr. Radford holds a doctorate degree from LaTrobe University.
Détentions connues dans des sociétés publiques
Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
---|---|---|---|---|
GENETIC SIGNATURES LTD.
0,13% | 30/06/2023 | 245 710 ( 0,13% ) | 109 004 $ | 31/03/2024 |
Postes actifs de Anthony Radford
Sociétés | Poste | Début |
---|---|---|
GENETIC SIGNATURES LIMITED | Director/Board Member | 15/09/2015 |
Anciens postes connus de Anthony Radford
Sociétés | Poste | Fin |
---|---|---|
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Founder | 01/10/2012 |
Amrad Operations Pty Ltd. | Corporate Officer/Principal | 01/12/2000 |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Corporate Officer/Principal | 01/12/1992 |
Formation de Anthony Radford
LaTrobe University | Doctorate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 4 |
---|---|
Cellestis Pty Ltd.
Cellestis Pty Ltd. BiotechnologyHealth Technology Cellestis Ltd. develops, manufactures and markets medical diagnostic products. It develops and markets QuantiFERON technology products for medical diagnosis and scientific research. The QuantiFERON technology is a patented whole blood method for detecting cell mediated immune responses of T cell lymphocytes using whole blood samples. Its product portfolio includes QuantiFERON-CMI kit, an in vitro laboratory test for the measurement of cell mediated immune responses in humans using whole blood, QuantiFERON-TB Gold, an in vitro diagnostic test for the detection of mycobacterium tuberculosis infection. The company was founded in 2000 and is headquartered in Chadstone, Australia. | Health Technology |
Genetic Signatures Ltd. | |
Commonwealth Scientific & Industrial Research Organisation
Commonwealth Scientific & Industrial Research Organisation Miscellaneous Commercial ServicesCommercial Services Commonwealth Scientific & Industrial Research Organisation provides scientific and industrial research services. It plays a role in collaboration within the Australian national innovation system and as an advisor to government, industry and the community. The company was founded in 1916 and is headquartered in Canberra, Australia. | Commercial Services |
Amrad Operations Pty Ltd. |